Case Western Reserve University

JumpStart Board of Directors Names Julie Jacono As New CEO

Retrieved on: 
Wednesday, November 29, 2023
Biomedical engineering, Leach, Health equity, The, Harvard Business School, JumpStart, MetroHealth, Entrepreneurship, Jacono, MBA, Communication, Case Western Reserve University, Innovation, Management, Health care, Jump start

CLEVELAND, Nov. 29, 2023 /PRNewswire/ -- JumpStart's Board of Directors has named Julie Jacono as its new CEO, following an extensive national search.

Key Points: 
  • CLEVELAND, Nov. 29, 2023 /PRNewswire/ -- JumpStart's Board of Directors has named Julie Jacono as its new CEO, following an extensive national search.
  • "Julie is an inspirational leader with a proven ability to innovate and transform organizations," said Jeanne Coughlin, JumpStart's board chair.
  • Her deep experience in health care, a critical industry in Northeast Ohio, will introduce a fresh viewpoint to JumpStart.
  • "I am grateful to the board for giving me this opportunity to lead the talented team at JumpStart," Jacono said.

Carnegie Investment Counsel Strengthens Executive Leadership With Key Organizational Changes, Welcomes Joe Spidalieri to Serve as Chief Operating Officer

Retrieved on: 
Wednesday, November 15, 2023
Registered investment adviser, Weatherhead School of Management, American Express, Miami University, Hire, Case Western Reserve University, Richard Wagner, Growth, AUM, Knowledge, RIA, Management, Financial adviser

CLEVELAND, Nov. 15, 2023 /PRNewswire/ -- Carnegie Investment Counsel ("Carnegie"), a leading privately owned Registered Investment Adviser (RIA) with over $3.8B in assets under management, is pleased to announce the addition of Joe Spidalieri as the firm's new Chief Operating Officer. Spidalieri's rich experience in the financial and wealth management space will play a pivotal role in supporting Carnegie's core growth goals and ensuring operational excellence.

Key Points: 
  • In step with Spidalieri's appointment to COO, Carnegie has appointed Richard Alt to CEO and Gary Wagner to President.
  • These internal leadership changes underscore the firm's dedication to both long-term organizational growth and the continued delivery of exceptional service to our clients.
  • "Carnegie is renowned within the industry for their client-oriented values and impressive track record," says Spidalieri.
  • Spidalieri brings with him over two decades of industry experience, most recently acting as Chief Operating Officer for Ancora.

Centerline Biomedical announces New CFO Indrani Egleston

Retrieved on: 
Monday, November 13, 2023
Center line, Internal audit, Radiation, Indrani, University, CFO, Patient, Master, Bachelor of Business Administration, Mergers and acquisitions, Caregiver, Business administration, Egleston, Lead, Nordson Corporation, Case Western Reserve University, Master of Business Administration, Management

CLEVELAND, Nov. 13, 2023 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovator in cardiovascular visualization and navigation systems, today announced the appointment of Indrani Egleston to the position of Chief Financial Officer (CFO).

Key Points: 
  • CLEVELAND, Nov. 13, 2023 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovator in cardiovascular visualization and navigation systems, today announced the appointment of Indrani Egleston to the position of Chief Financial Officer (CFO).
  • She most recently served as CFO of Signature Health, a healthcare organization in Northeast Ohio.
  • Prior to Signature Health, Ms. Egleston had advancing financial leadership positions at large public companies in Northeast Ohio, notably Covia (formerly Fairmount Santrol) and Nordson Corporation.
  • "We are delighted to welcome Indrani Egleston to Centerline to lead and grow our financial team.

Body Expert AMG Plastic Surgery Joins Exclusive Haute Beauty Network

Retrieved on: 
Thursday, November 9, 2023
Child, Pittsburgh Steelers, Beauty, Torso, Breast reconstruction, Cooking, Case Western Reserve University, Family, Face, Maimonides Medical Center, Plastic, Health, Research, Master, Business administration, Abstract, Cleveland Clinic, Breast cancer, Sensation, Tennis, General surgery, Safety, Education, Master of Business Administration, AMG, Breast, Patient, Master's degree, Dentistry, Nursing, DMV, Microsurgery, Empathy

NEW YORK, Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. Amir Mahan Ghaznavi is a dual-board certified plastic surgeon and a leader in the field of plastic surgery. He completed his general surgery training at Maimonides Medical Center in Brooklyn, NY. Upon completion, Dr. Ghaznavi continued his plastic surgery training at the distinguished Henry Ford Hospital System. Dr. Ghaznavi concluded his training in Microsurgery at the renowned Cleveland Clinic Foundation under the guidance of leading experts in his specialty.

Key Points: 
  • AMG Plastic Surgery joins Haute Beauty Network as a body expert representing the DMV market.
  • NEW YORK, Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. Amir Mahan Ghaznavi is a dual-board certified plastic surgeon and a leader in the field of plastic surgery.
  • Upon completion, Dr. Ghaznavi continued his plastic surgery training at the distinguished Henry Ford Hospital System.
  • AMG Plastic Surgery sees clients for all their cosmetic and reconstructive needs of the face, breast, and body.

Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day

Retrieved on: 
Thursday, November 9, 2023
Esophageal cancer, AMP, Research, CLIA, National Cancer Institute, Esophageal disease, Case Western Reserve University, Lucid, CCNA1, Methylation, NGS, VIM, Polymerase chain reaction, Gene, Cancer, Invention, DNA, Vaccine

NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that its CAP-accredited, CLIA-certified laboratory, LucidDx Labs, Inc., has launched the next generation of the EsoGuard® Esophageal DNA test ("EsoGuard 2.0") for the detection of esophageal precancer, having demonstrated enhanced assay performance and lower costs in extensive validation studies. All commercial and research samples received by the laboratory will now be processed using the EsoGuard 2.0 assay. Lucid also announced that it will be hosting an Investor Day on December 13, 2023, in New York City.

Key Points: 
  • Lucid also announced that it will be hosting an Investor Day on December 13, 2023, in New York City.
  • The EsoGuard assay involves first extracting DNA from esophageal cells collected by the EsoCheck® Cell Collection Device.
  • Lucid will host an Investor Day event to be held in New York, NY on December 13, 2023.
  • Details on how to register for the Investor Day will be made available on the Investor Relations section of the Company's website.

Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting

Retrieved on: 
Thursday, November 2, 2023
Mechanism of action, Trial of the century, AACR, Vomiting, Lung cancer, Drug, Conference, Doctor of Philosophy, Carcinoma, CDK9, Nausea, KRON, Kronos, Learning, Case Western Reserve University, Ewing sarcoma, Washington University School of Medicine, Neoplasm, Sarcoma, Safety, Cancer, Patient, Neutropenia, SAN, Rhabdomyosarcoma, Fatigue, Pharmaceutical industry, Medicine

SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced the presentation of positive preliminary data from the phase 1 dose escalation portion of the ongoing phase 1/2 KB-0742 study at the Connective Tissue Oncology Society annual meeting in Dublin, Ireland. Today’s presentation by Dr. Van Tine of Washington University School of Medicine includes clinical data that was first presented at the AACR-NCI-EORTC International Conference on October 13, 2023, in Boston, Massachusetts in the context of pre-clinical models that provide a better understanding of the observed anti-tumor activity. Preclinical studies led by Berkley Gryder, PhD, of Case Western Reserve University demonstrated KB-0742's on-mechanism activity in transcription factor fusion positive models for rhabdomyosarcoma and Ewing sarcoma.

Key Points: 
  • Preclinical studies led by Berkley Gryder, PhD, of Case Western Reserve University demonstrated KB-0742's on-mechanism activity in transcription factor fusion positive models for rhabdomyosarcoma and Ewing sarcoma.
  • Today, I shared a case study on one of my sarcoma patients who exhausted all standard therapies as well as multiple experimental treatments.
  • The preliminary analysis included 28 patients enrolled in a dose escalation study who received doses from 10 mg up to 60 mg (data cut-off September 1st, 2023).
  • To learn more about the preliminary positive KB-0742 data presented at the AACR-NCI-EORTC International Conference on October 13, 2023, in Boston, Mass.

Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors

Retrieved on: 
Wednesday, October 25, 2023
Eli Lilly and Company, American Red Cross, Duke University, Obesity, Diabetes, PALO, Non-U.S. operators of the M60 Patton, Case Western Reserve University, The Conference Board, Business administration, Marketing, Retirement, Mechanical, Master of Business Administration, Patient, Mechanical engineering, Pharmaceutical industry, Lilly, Glooko

Mr. Conterno is a well-known executive in the pharmaceutical industry with deep expertise in the diabetes field.

Key Points: 
  • Mr. Conterno is a well-known executive in the pharmaceutical industry with deep expertise in the diabetes field.
  • He joins the board of Glooko having served most recently as the Chief Executive Officer and a member of the Board at FibroGen, Inc. Before FibroGen, Mr. Conterno was Senior Vice President for Eli Lilly and Company, serving as President of Lilly USA from January 2017, and President of Lilly Diabetes from 2009, until his retirement from Lilly in December 2019.
  • "Glooko brings innovative digital health solutions to patients, providers, and clinical and pharmaceutical companies around the world.
  • I am excited to leverage my insights to help Glooko to reach its full potential."

California State Treasurer, Fiona Ma, and US-India cross-border association, AllianceIndus, congratulate Hemex Health for India partnerships that led to a breakthrough test for sickle cell disease

Retrieved on: 
Wednesday, October 18, 2023
Hemoglobinopathy, SCD, Organizational founder, Reading, Ship, CWRU, Sickle cell disease, Case Western Reserve University, Beta thalassemia, Woman, SAN, Medical device

The Hemex Diagnostic Platform, Gazelle™, supports a powerful test for hemoglobinopathies including SCD and beta thalassemia and was launched into the Indian market in early 2021.

Key Points: 
  • The Hemex Diagnostic Platform, Gazelle™, supports a powerful test for hemoglobinopathies including SCD and beta thalassemia and was launched into the Indian market in early 2021.
  • It is manufactured in India and currently ships from India to over 30 countries.
  • “Hemex utilized invention from Case Western Reserve University (CWRU), Hemex’s experience in low-cost design, and India’s competitive manufacturing.
  • This winning combination will help us realize our vision of improving access to accurate testing.”
    Please click here to continue reading.

Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business

Retrieved on: 
Thursday, October 19, 2023
Biotechnology, General Health, Medical Devices, Health, Pharmaceutical, CRL, National meetings of the Workers' Party of Korea, Human, Case Western Reserve University, NYSE, AALAS, Research, Online shopping

The introduction of real-time ordering for Charles River’s Research Models & Services business digitizes a robust, industry-leading inventory, and provides a seamless online ordering experience.

Key Points: 
  • The introduction of real-time ordering for Charles River’s Research Models & Services business digitizes a robust, industry-leading inventory, and provides a seamless online ordering experience.
  • “Traditionally, clients looking to purchase research models would review a static digital catalog, and follow-up with a phone call or email to our ordering team,” said Colin Dunn, Ph.D., Corporate Senior Vice President, Global Research Models & Services, Charles River.
  • “Implementing this real-time experience in our Research Models & Services business is the latest in a series of innovations that are fundamental to our digital journey,” said Mark Mintz, Corporate Senior Vice President, Chief Information Officer at Charles River.
  • Visit Booth #1908 for a demonstration from subject matter experts, and to see the latest innovations from Charles River.

BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award

Retrieved on: 
Thursday, October 12, 2023
Agilent Technologies, Neoplasm, C, Antibody, Lowell Thomas, BASF, Personality, Therapy, Case Western Reserve University, Conditional, Biotechnology, Nature Biotechnology, Doctor of Philosophy, Taylor University, The Explorers Club, MIT, Chemistry, Operation, Biochemistry, Award, SAN, Science, PACS, IPO, Are You Serious (Andrew Bird album), CAB, Pharmaceutical industry, Vaccine

Dr. Short’s award is in recognition of his contribution to science innovation throughout his career.

Key Points: 
  • Dr. Short’s award is in recognition of his contribution to science innovation throughout his career.
  • The Lowell Thomas Award is named after the renowned broadcast journalist, filmmaker and explorer and was first given in 1980 to mark the 75th anniversary of The Explorers Club, a multidisciplinary, professional society dedicated to the advancement of field research, scientific exploration and resource conservation.
  • This annual Award is given thematically to a group of outstanding explorers to recognize excellence in domains or fields of exploration.
  • Among the many notable recipients of the Award in past years are Carl Sagan, Sir David Attenborough, “Buzz” Aldrin, Sylvia Earle and Sir Edmund Hillary.